Commentary

Commentary

What are your weaknesses?

What would it look like if we started treating ourselves less like physicians and more like patients?

Commentary

Drugging the undruggable

Targeted therapies are the ideal in drug development. New drugs that target KRAS (G12C) mutations mark a significant leap forward in oncology.

The Practicing Oncologist

My picks for best of ASCO 2022

First-line treatment for colorectal cancer, possible new standard of care for breast cancer, and more.

Pages